Benzinga | Nov 9, 2020 04:04PM EST

OptimizeRx Q3 Adj. EPS $0.07 Beats $0.04 Estimate, Sales $10.50M Beat $9.77M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.04 by 75 percent. This is a 240 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $10.50 million which beat the analyst consensus estimate of $9.77 million by 7.47 percent. This is a 109.87 percent increase over sales of $5.00 million the same period last year.